A case report of the successful treating of atrial flutter whis the persistent left-sided superior vena cava

Филатов, А.Г.; Ступаков, С. И.; Shafiev, E.Kh.; Fatulaev, Z.F.; Yakh'yaev, Ya.B.

doi:10.15275/annaritmol.2019.2.3

AnnAritmol

2019

DOI: 10.15275/annaritmol.2019.2.3

|View full text |Cite

A case report of the successful treating of atrial flutter whis the persistent left-sided superior vena cava

А.Г. Филатов¹,

С. И. Ступаков²,

E.Kh. Shafiev³

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2023

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Relief of persistent atypical atrial flutter: experience with the use of niferidil

Zakharyan¹,

Shatov²,

Povoroznyj³

et al. 2023

Racionalʹnaâ farmakoterapiâ v kardiologii

View full text Add to dashboard Cite

An increase in life expectancy contributes to a steady growth of diseases of the cardiovascular system. In recent years, there has been a stable increase in the prevalence of rhythm disturbances in the population. Fibrillation and atrial flutter are among the most common causes of a decrease in the quality of life and an increase in mortality. However, the effectiveness of various methods of treatment is not absolute, and therefore the development and introduction of new antiarrhythmic drugs is particularly relevant. Thus, the use of a class III antiarrhythmic drug (niferidil) is of unconditional interest, and literature data describing the effectiveness of its use for the relief of atypical atrial flutter are extremely few. The article presents a case of successful relief of a persistent form of atypical atrial flutter in a 79-year-old patient using three consecutive intravenous injections of niferidil at a dose of 10 mcg/kg with a 15-minute interval in 19 hours after the start of therapy. The presented clinical case confirms the effectiveness of drug cardioversion with the use of niferidil and makes it possible to consider it as an alternative to electrical cardioversion in patients with atypical atrial flutter.

show abstract

Relief of persistent atypical atrial flutter: experience with the use of niferidil

Zakharyan¹,

Shatov²,

Povoroznyj³

et al. 2023

Racionalʹnaâ farmakoterapiâ v kardiologii

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

A case report of the successful treating of atrial flutter whis the persistent left-sided superior vena cava

Cited by 1 publication

References 0 publications

Relief of persistent atypical atrial flutter: experience with the use of niferidil

Relief of persistent atypical atrial flutter: experience with the use of niferidil

Contact Info

Product

Resources

About